These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Regenerative cellular therapies for neurologic diseases. Levy M; Boulis N; Rao M; Svendsen CN Brain Res; 2016 May; 1638(Pt A):88-96. PubMed ID: 26239912 [TBL] [Abstract][Full Text] [Related]
7. Regenerative medicine for spinal cord injury: focus on stem cells and biomaterials. Papa S; Pizzetti F; Perale G; Veglianese P; Rossi F Expert Opin Biol Ther; 2020 Oct; 20(10):1203-1213. PubMed ID: 32421405 [TBL] [Abstract][Full Text] [Related]
8. Regenerative medicine for the treatment of spinal cord injury: more than just promises? Pêgo AP; Kubinova S; Cizkova D; Vanicky I; Mar FM; Sousa MM; Sykova E J Cell Mol Med; 2012 Nov; 16(11):2564-82. PubMed ID: 22805417 [TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic strategies using nanodrug delivery, stem cells and combination therapy for CNS trauma and neurodegenerative disorders. Sharma HS; Muresanu DF; Sharma A Expert Rev Neurother; 2013 Oct; 13(10):1085-8. PubMed ID: 24089700 [TBL] [Abstract][Full Text] [Related]
10. Regenerative neuroimmunology: The impact of immune and neural stem cell interactions for translation in neurodegeneration and repair. Imitola J J Neuroimmunol; 2019 Jun; 331():1-3. PubMed ID: 31023492 [No Abstract] [Full Text] [Related]
11. [Neural repair]. Kitada M; Dezawa M Nihon Rinsho; 2008 May; 66(5):921-5. PubMed ID: 18464511 [TBL] [Abstract][Full Text] [Related]
12. Stem cells as a resource for regenerative neurology. Connick P; Patani R; Chandran S Pract Neurol; 2011 Feb; 11(1):29-36. PubMed ID: 21239652 [TBL] [Abstract][Full Text] [Related]
13. Stem cells in canine spinal cord injury--promise for regenerative therapy in a large animal model of human disease. McMahill BG; Borjesson DL; Sieber-Blum M; Nolta JA; Sturges BK Stem Cell Rev Rep; 2015 Feb; 11(1):180-93. PubMed ID: 25173879 [TBL] [Abstract][Full Text] [Related]
14. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell]. Nakamura M; Toyama Y; Okano H Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863 [TBL] [Abstract][Full Text] [Related]
15. Stem cells in human neurodegenerative disorders--time for clinical translation? Lindvall O; Kokaia Z J Clin Invest; 2010 Jan; 120(1):29-40. PubMed ID: 20051634 [TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of human olfactory-derived stem cells. Marshall CT; Lu C; Winstead W; Zhang X; Xiao M; Harding G; Klueber KM; Roisen FJ Histol Histopathol; 2006 Jun; 21(6):633-43. PubMed ID: 16528674 [TBL] [Abstract][Full Text] [Related]
17. Stem cells as a novel tool for drug screening and treatment of degenerative diseases. Zuba-Surma EK; Wojakowski W; Madeja Z; Ratajczak MZ Curr Pharm Des; 2012; 18(18):2644-56. PubMed ID: 22512442 [TBL] [Abstract][Full Text] [Related]
18. The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury. Yu C; Xia K; Gong Z; Ying L; Shu J; Zhang F; Chen Q; Li F; Liang C Curr Stem Cell Res Ther; 2019; 14(6):495-503. PubMed ID: 30924422 [TBL] [Abstract][Full Text] [Related]
19. Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders. Vatsa P; Negi R; Ansari UA; Khanna VK; Pant AB Mol Neurobiol; 2022 Jan; 59(1):459-474. PubMed ID: 34714469 [TBL] [Abstract][Full Text] [Related]